nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentagastrin—CCKBR—G alpha (q) signalling events—MGLL—osteoporosis	0.0578	0.0578	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.0517	0.0517	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—PTH1R—osteoporosis	0.0367	0.0367	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—CALCR—osteoporosis	0.0367	0.0367	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.0288	0.0288	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.0247	0.0247	CbGpPWpGaD
Pentagastrin—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—osteoporosis	0.0244	0.0244	CbGpPWpGaD
Pentagastrin—BCHE—Glycerophospholipid biosynthesis—MGLL—osteoporosis	0.0223	0.0223	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—PTH1R—osteoporosis	0.0207	0.0207	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—CALCR—osteoporosis	0.0207	0.0207	CbGpPWpGaD
Pentagastrin—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—osteoporosis	0.0201	0.0201	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—PTH—osteoporosis	0.0193	0.0193	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—CALCR—osteoporosis	0.0188	0.0188	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PTH1R—osteoporosis	0.0188	0.0188	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—CNR2—osteoporosis	0.0188	0.0188	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—WNT1—osteoporosis	0.0177	0.0177	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—REN—osteoporosis	0.0173	0.0173	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—MGLL—osteoporosis	0.0165	0.0165	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—PTHLH—osteoporosis	0.016	0.016	CbGpPWpGaD
Pentagastrin—BCHE—Phospholipid metabolism—MGLL—osteoporosis	0.0155	0.0155	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—MGLL—osteoporosis	0.015	0.015	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—POMC—osteoporosis	0.0144	0.0144	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—CALCA—osteoporosis	0.0141	0.0141	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.0127	0.0127	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—SOST—osteoporosis	0.0123	0.0123	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—CALCR—osteoporosis	0.0111	0.0111	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PTH1R—osteoporosis	0.0111	0.0111	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—PTH—osteoporosis	0.0109	0.0109	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—ACE—osteoporosis	0.0108	0.0108	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—CNR2—osteoporosis	0.0106	0.0106	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PTH—osteoporosis	0.00989	0.00989	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00966	0.00966	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—CNR2—osteoporosis	0.00964	0.00964	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—WNT1—osteoporosis	0.00906	0.00906	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—PTHLH—osteoporosis	0.00902	0.00902	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—MGLL—osteoporosis	0.00883	0.00883	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—LRP5—osteoporosis	0.00862	0.00862	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—LRP6—osteoporosis	0.00825	0.00825	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PTHLH—osteoporosis	0.00819	0.00819	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—CALCA—osteoporosis	0.00794	0.00794	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—POMC—osteoporosis	0.00735	0.00735	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—CALCA—osteoporosis	0.00721	0.00721	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—TLN1—osteoporosis	0.00696	0.00696	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.00696	0.00696	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—LEP—osteoporosis	0.00673	0.00673	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.0066	0.0066	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—P4HB—osteoporosis	0.00601	0.00601	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PTH—osteoporosis	0.00584	0.00584	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—POMC—osteoporosis	0.00578	0.00578	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—RAP1A—osteoporosis	0.00574	0.00574	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—CCT2—osteoporosis	0.0057	0.0057	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—CNR2—osteoporosis	0.00569	0.00569	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.00567	0.00567	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—ADCY5—osteoporosis	0.00565	0.00565	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—NFATC1—osteoporosis	0.0056	0.0056	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—IGF1—osteoporosis	0.00556	0.00556	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—DKK1—osteoporosis	0.00556	0.00556	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—WNT1—osteoporosis	0.00535	0.00535	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—FGA—osteoporosis	0.00521	0.00521	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.00513	0.00513	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—ADCY5—osteoporosis	0.00513	0.00513	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.005	0.005	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—TUBA1B—osteoporosis	0.00485	0.00485	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PTHLH—osteoporosis	0.00484	0.00484	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—BMP2—osteoporosis	0.00484	0.00484	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—FGB—osteoporosis	0.00474	0.00474	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PSMA2—osteoporosis	0.00457	0.00457	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PSMA5—osteoporosis	0.00457	0.00457	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—CALCA—osteoporosis	0.00426	0.00426	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—POMC—osteoporosis	0.00416	0.00416	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.004	0.004	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.00396	0.00396	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—RPL24—osteoporosis	0.00388	0.00388	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—KL—osteoporosis	0.00387	0.00387	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—POMC—osteoporosis	0.00377	0.00377	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—IL6R—osteoporosis	0.00368	0.00368	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—TLN1—osteoporosis	0.00341	0.00341	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.0034	0.0034	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—REN—osteoporosis	0.00328	0.00328	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PKM—osteoporosis	0.0031	0.0031	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—FDPS—osteoporosis	0.0031	0.0031	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—ADCY5—osteoporosis	0.00304	0.00304	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ADCY5—osteoporosis	0.00303	0.00303	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GPD2—osteoporosis	0.00294	0.00294	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PGLS—osteoporosis	0.00294	0.00294	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—SPP1—osteoporosis	0.00293	0.00293	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—ATIC—osteoporosis	0.00269	0.00269	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PNP—osteoporosis	0.00269	0.00269	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IRS2—osteoporosis	0.00265	0.00265	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—LEP—osteoporosis	0.0026	0.0026	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ESR1—osteoporosis	0.00248	0.00248	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IRS1—osteoporosis	0.00232	0.00232	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CA2—osteoporosis	0.00229	0.00229	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—OXCT1—osteoporosis	0.00229	0.00229	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—POMC—osteoporosis	0.00223	0.00223	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—MGLL—osteoporosis	0.00223	0.00223	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IL6R—osteoporosis	0.00217	0.00217	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IGF1—osteoporosis	0.00214	0.00214	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.0021	0.0021	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—ACE—osteoporosis	0.00204	0.00204	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—IDH2—osteoporosis	0.00189	0.00189	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CYP27A1—osteoporosis	0.00178	0.00178	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—ACP5—osteoporosis	0.00173	0.00173	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.00171	0.00171	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—IL6—osteoporosis	0.00164	0.00164	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—TPI1—osteoporosis	0.00161	0.00161	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—P4HB—osteoporosis	0.00151	0.00151	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GAPDH—osteoporosis	0.00149	0.00149	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—RAP1A—osteoporosis	0.00145	0.00145	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—MYC—osteoporosis	0.00129	0.00129	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—TGFB1—osteoporosis	0.00129	0.00129	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—LEP—osteoporosis	0.00127	0.00127	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.00126	0.00126	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—ENO1—osteoporosis	0.00117	0.00117	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PSMA2—osteoporosis	0.00115	0.00115	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PSMA5—osteoporosis	0.00115	0.00115	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—POMC—osteoporosis	0.00109	0.00109	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—IGF1—osteoporosis	0.00105	0.00105	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IL6—osteoporosis	0.000969	0.000969	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CYP19A1—osteoporosis	0.000935	0.000935	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—ADCY5—osteoporosis	0.000764	0.000764	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GPX1—osteoporosis	0.000762	0.000762	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—MTHFR—osteoporosis	0.000703	0.000703	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—POMC—osteoporosis	0.000562	0.000562	CbGpPWpGaD
